SOCS-1, a Negative Regulator of Cytokine Signaling, Is Frequently Silenced by Methylation in Multiple Myeloma

Blood - United States
doi 10.1182/blood-2002-06-1735
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Dysregulation of SOCS-Mediated Negative Feedback of Cytokine Signaling in Carcinogenesis and Its Significance in Cancer Treatment

Frontiers in Immunology
AllergyImmunology
2017English

The Systemic Cytokine Environment Is Permanently Altered in Multiple Myeloma

PLoS ONE
Multidisciplinary
2013English

Genomic Screening for Genes Silenced by DNA Methylation Revealed an Association Between RASD1 Inactivation and Dexamethasone Resistance in Multiple Myeloma

Clinical Cancer Research
Cancer ResearchOncology
2009English

Methylation of SOCS-3 and SOCS-1 in the Carcinogenesis of Barrett's Adenocarcinoma

Gut
Gastroenterology
2007English

Neuraminidase-3 Is a Negative Regulator of LFA-1 Adhesion

Frontiers in Chemistry
Chemistry
2019English

The microRNA miR-8 Is a Conserved Negative Regulator of WNT Signaling

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Suppressors of Cytokine Signaling (SOCS) in T Cell Differentiation, Maturation, and Function

Trends in Immunology
AllergyImmunology
2009English

The Adaptor Protein Tom1L1 Is a Negative Regulator of SRC Mitogenic Signaling Induced by Growth Factors

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2006English

Lactate Dehydrogenase-B Is Silenced by Promoter Methylation in a High Frequency of Human Breast Cancers

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy